	C 2012 Mar 31	2013 Mar 31	2014 Mar 31	R 2015 Mar 31	2016 Mar 31	R 2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Total Revenue	136.44	130.69	134.32	157.64	176.65	206.89	220.00	253.23	261.48	332.84	405.84	379.64	421.23	451.82	502.55
Cost of Operating Revenue	70.17	65.72	62.26	67.80	72.06	86.36	100.55	123.92	123.45	145.61	186.92	190.25	221.73	233.25	250.68
Gross Profit	66.27	64.97	72.05	89.84	104.59	120.53	119.45	129.31	138.03	187.23	218.92	189.39	199.50	218.57	251.87
Gross Margin	48.6	49.7	53.6	57.0	59.2	58.3	54.3	51.1	52.8	56.3	53.9	49.9	47.4	48.4	50.1
Total Operating Expenses	121.87	116.96	116.08	137.26	149.02	178.90	194.81	224.85	235.12	261.76	330.16	340.25	374.59	399.94	433.19
Operating Profit	14.57	13.73	18.24	20.38	27.63	27.99	25.19	28.37	26.35	71.08	75.68	39.39	46.64	51.88	69.37
Operating Margin	10.7	10.5	13.6	12.9	15.6	13.5	11.5	11.2	10.1	21.4	18.6	10.4	11.1	11.5	13.8
Financing Income/(Expense) - Net	0.55	0.53	0.15	2.84	3.84	-0.13	4.42	5.35	6.48	8.95	10.81	11.94	14.71	15.80	-0.20
Profit before Taxes	15.79	15.47	19.38	24.15	32.68	35.10	32.96	35.17	34.45	81.90	90.58	53.65	61.95	69.13	77.89
Income Taxes	6.16	5.36	6.94	9.25	12.11	11.99	12.91	10.17	9.37	20.71	23.39	13.81	16.97	18.30	19.97
Profit after Tax	9.63	10.12	12.44	14.90	20.58	21.80	19.97	24.51	25.08	61.19	67.19	39.83	44.97	50.83	57.92
PAT Margin	7.1	7.7	9.3	9.5	11.6	10.5	9.1	9.7	9.6	18.4	16.6	10.5	10.7	11.3	11.5
EPS - Basic - ex Extraordinary Items	3.25	3.46	4.26	5.10	7.04	7.91	6.86	8.55	8.58	20.94	23.00	13.65	15.50	17.58	20.03
EPS - Diluted - ex Extraordinary Items	3.25	3.46	4.26	5.10	7.04	7.91	6.86	8.55	8.58	20.93	22.98	13.63	15.50	17.58	20.03
EBIT	14.57	13.73	18.24	20.38	27.63	27.99	25.19	28.37	26.35	71.08	75.68	39.39	46.64	51.88	69.37
EBITDA	18.12	17.45	21.84	23.59	30.98	30.03	28.10	31.53	30.71	74.75	79.47	44.60	52.70	58.40	75.68
EBITDA Margin	13.3	13.4	16.3	15.0	17.5	14.5	12.8	12.5	11.7	22.5	19.6	11.7	12.5	12.9	15.1

Balance Sheet

Abridged

Understanding Balance Sheet

Amrutanjan Health Care Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	R 2012 Mar 31	2013 Mar 31	C 2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	R 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	PRESS
Total Current Assets	60.67	63.38	78.25	82.84	88.83	108.18	121.35	139.62	125.82	222.90	274.65	259.54	295.68	290.67	291.65
Long-Term Investments	24.81	24.93	9.13	9.10	10.51	8.71	11.69	16.09	45.33	20.15	22.31	43.05	11.78	41.70	46.24
Property Plant & Equipment - Net	32.67	30.24	27.64	27.71	26.64	27.71	27.33	25.28	25.57	23.32	43.47	47.55	49.54	63.93	155.29
Total Non-Current Assets	63.37	60.69	42.02	41.06	42.36	44.03	44.90	48.00	79.52	51.37	75.22	102.55	71.19	130.72	217.24
Total Assets	124.21	124.16	120.27	123.90	131.19	152.21	166.25	187.61	205.35	274.27	349.87	362.09	366.87	421.39	508.89
Total Current Liabilities	36.66	37.99	27.25	25.85	29.07	32.28	32.38	36.12	39.06	52.10	77.47	63.01	69.92	84.58	126.18
Long Term Debt	6.11	-	-	-	-	-	-	-	1.12	0.70	0.31	0.40	1.40	1.68	1.42
Total Non-Current Liabilities	10.28	3.90	3.78	3.10	3.92	4.22	5.22	5.76	6.86	6.60	7.27	8.31	8.46	10.19	12.47
Total Liabilities	46.94	41.89	31.03	28.95	32.99	36.50	37.59	41.88	45.92	58.71	84.74	71.32	78.38	94.77	138.66
Total Shareholders' Equity	77.27	82.27	89.24	94.95	98.20	115.71	128.66	145.74	159.43	215.56	265.12	290.77	288.49	326.61	370.23
Total Equity	77.27	82.27	89.24	94.95	98.20	115.71	128.66	145.74	159.43	215.56	265.12	290.77	288.49	326.61	370.23
Total Liabilities & Equity	124.21	124.16	120.27	123.90	131.19	152.21	166.25	187.61	205.35	274.27	349.87	362.09	366.87	421.39	508.89

Cash Flow

Abridged

Understanding Cash Flow Statement

Amrutanjan Health Care Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	R 2013 Mar 31	2014 Mar 31	C 2015 Mar 31	2016 Mar 31	R 2017 Mar 31	R 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	14.51	12.92	16.56	16.36	23.32	24.01	24.60	27.17	28.59	65.86	68.76	41.05	52.19	57.92	64.10
Working Capital - Increase/(Decrease)	-10.13	-4.38	1.91	3.22	0.81	-10.92	0.47	-0.81	-4.29	29.51	-3.93	-9.64	-10.16	9.02	-12.21
Net CF from Operating Activities	4.38	8.54	18.47	19.58	24.13	13.09	25.07	26.36	24.30	95.37	64.83	31.41	42.03	66.95	51.89
Capital Expenditures - Net	3.99	0.94	0.77	5.75	1.26	3.75	0.97	1.97	2.54	1.87	23.46	8.88	6.46	35.55	54.90
Net CF from Investing Activities	10.94	5.32	13.80	-6.89	0.34	-4.30	-13.85	-15.81	-20.00	-93.40	-48.85	-13.71	5.04	-47.01	-37.15
Dividends Paid - Cash - Total	5.10	5.10	5.13	5.69	10.99	4.08	5.63	5.70	9.21	4.68	12.48	14.41	13.39	13.27	13.20
Stock - Issuance/(Retirement) - Net	-9.62	-	-	-	-	-	-	-	-	-0.96	-3.53	-	-27.62	0.24	0.07
Debt - LT & ST - Issuance/(Retirement) - Total	-9.67	-6.67	-7.12	-5.50	-1.72	-0.02	-2.48	-	-0.56	-0.64	-0.69	-0.58	-0.56	-0.46	-0.50
Net Cash Flow from Financing Activities	-24.50	-11.77	-12.25	-11.19	-12.71	-4.10	-9.26	-6.87	-11.66	-6.28	-16.70	-14.99	-48.27	-13.49	-13.62
Free Cash Flow to Equity	-9.28	0.93	10.58	8.33	21.15	9.32	21.62	24.39	21.19	92.85	40.67	21.95	35.01	30.93	-3.51
Free Operating CF net dividend	-13.49	2.11	12.21	8.08	10.94	5.20	16.38	18.62	12.55	88.73	28.89	8.08	21.93	18.13	-16.31
Free Operating CF	-8.39	7.21	17.34	13.77	21.93	9.28	22.01	24.32	21.75	93.41	41.37	22.49	35.31	31.39	-3.12

Business Segment Analysis

FY End:

Mar 25

Amrutanjan Health Care Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Women Hygiene (82.4%)₹ 16.20 CrOthers (8.7%)₹ 1.72 CrOTC Products (8.3%)₹ 1.62 CrBeverages (0.7%)₹ 0.13 Cr

Revenue / Sales

OTC Products (64.2%)₹ 290.03 CrWomen Hygiene (27.4%)₹ 123.96 CrBeverages (8.1%)₹ 36.43 CrOthers (0.3%)₹ 1.39 Cr

Assets

Unallocated (62.9%)₹ 265.04 CrOTC Products (16.1%)₹ 68.01 CrWomen Hygiene (12.4%)₹ 52.09 CrBeverages (8.3%)₹ 35.03 CrOthers (0.3%)₹ 1.22 Cr

Regional Segment Analysis

FY End:

Mar 25

Amrutanjan Health Care Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

India (98.2%)₹ 442.31 CrOther countries (1.8%)₹ 8.19 Cr

Historical Segment Analysis

Track how Amrutanjan Health Care Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2010 Mar 31	2011 Mar 31	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2024 Mar 31	2025 Mar 31

Women Hygiene	-	-	-	-	-	-	-	-	-	16
Others	0	0	1	0	0	1	0	0	1	2
OTC Products	1	10	3	1	0	1	8	2	6	2
Beverages	-	0	1	0	0	0	0	2	0	0
Pharmaessense	1	6	0	0	0	0	0	-	-	-
Unallocated	0	0	-	-	-	1	0	-	-	-

Frequently Asked Questions

What is the revenue of Amrutanjan Health Care Ltd.?

The latest trailing twelve month revenue of Amrutanjan Health Care Ltd. is ₹ 502.55 Cr, reflecting a 1-year growth of 11.23% and a 3-year CAGR of 9.80%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Amrutanjan Health Care Ltd.?

The latest trailing twelve month net profit (PAT) of Amrutanjan Health Care Ltd. is ₹ 57.92 Cr, with a 3-year earnings CAGR of 13.69%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Amrutanjan Health Care Ltd.?

The trailing twelve month EBITDA of Amrutanjan Health Care Ltd. is approximately ₹ 69.37 Cr (based on an operating margin of 13.80%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Amrutanjan Health Care Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Amrutanjan Health Care Ltd. is 20.03. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Amrutanjan Health Care Ltd.?

The debt-to-equity ratio of Amrutanjan Health Care Ltd. stands at 0.00. The interest coverage ratio is 355.72x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Amrutanjan Health Care Ltd.?

The estimated book value per share of Amrutanjan Health Care Ltd. is 128.12 (derived from a P/B ratio of 4.20 and market price of ₹ 537.90), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Amrutanjan Health Care Ltd.?

The trailing twelve month operating cash flow of Amrutanjan Health Care Ltd. is ₹ 51.89 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Amrutanjan Health Care Ltd. report consolidated or standalone financials?

Amrutanjan Health Care Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.